Metastatic Soft Tissue Sarcoma

Showing 1 - 14 of 14

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Metastatic Leiomyosarcoma, Metastatic Sarcoma, Metastatic Soft Tissue Sarcoma Trial (Computed Tomography, Magnetic Resonance

Not yet recruiting
  • Metastatic Leiomyosarcoma
  • +5 more
  • Computed Tomography
  • +3 more
  • (no location specified)
Feb 2, 2023

Metastatic Bone Sarcoma, Metastatic Malignant Tumor in the Lung, Metastatic Soft Tissue Sarcoma Trial in Buffalo (Cisplatin,

Recruiting
  • Metastatic Bone Sarcoma
  • +5 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Jan 24, 2023

Advanced Soft Tissue Sarcoma, Locally Advanced Angiosarcoma, Locally Advanced Leiomyosarcoma Trial in Portland (Doxorubicin

Active, not recruiting
  • Advanced Soft Tissue Sarcoma
  • +26 more
  • Doxorubicin Hydrochloride
  • +3 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Jan 6, 2023

Metastatic Soft Tissue Sarcoma, Advanced Soft Tissue Sarcoma Trial in Aurora (doxorubicin with AGEN1884 and AGEN2034)

Recruiting
  • Metastatic Soft Tissue Sarcoma
  • Advanced Soft Tissue Sarcoma
  • doxorubicin with AGEN1884 and AGEN2034
  • Aurora, Colorado
    University of Colorado Hospital
Jan 4, 2023

Locally Advanced Bone Sarcoma, Locally Advanced Dedifferentiated Liposarcoma, Locally Advanced Gastrointestinal Stromal Tumor

Active, not recruiting
  • Locally Advanced Bone Sarcoma
  • +20 more
  • Ipilimumab
  • +3 more
  • Anchorage, Alaska
  • +650 more
Oct 18, 2022

Metastatic Leiomyosarcoma, Metastatic Synovial Sarcoma, Metastatic Undifferentiated Pleomorphic Sarcoma Trial in Seattle

Recruiting
  • Metastatic Leiomyosarcoma
  • +17 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 13, 2022

Advanced Soft Tissue Sarcoma, Locally Advanced Soft Tissue Sarcoma, Metastatic Soft Tissue Sarcoma Trial in Seattle

Recruiting
  • Advanced Soft Tissue Sarcoma
  • +2 more
  • Nanoparticle Albumin-Bound Rapamycin
  • Pazopanib hydrochloride
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Aug 16, 2022

Metastatic Esophageal, Gastric Cancer, Metastatic Head and Neck Carcinoma Trial in Houston (LVGN3616 + LVGN6051 +

Recruiting
  • Metastatic Esophageal
  • +7 more
  • LVGN3616 + LVGN6051 + Nab-Paclitaxel
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 31, 2022

Advanced Soft Tissue Sarcoma, Metastatic Soft Tissue Sarcoma Trial in Santa Monica (Trabectedin, Ipilimumab, Nivolumab)

Recruiting
  • Advanced Soft Tissue Sarcoma
  • Metastatic Soft Tissue Sarcoma
  • Santa Monica, California
    Sarcoma Oncology Research Center
May 4, 2022

Metastatic Leiomyosarcoma, Metastatic Soft Tissue Sarcoma, Stage III Uterine Corpus Leiomyosarcoma AJCC v8 Trial in United

Recruiting
  • Metastatic Leiomyosarcoma
  • +10 more
  • Duarte, California
  • +4 more
Nov 4, 2021

Metastatic Soft Tissue Sarcoma Trial in France (Regorafenib, Placebo)

Recruiting
  • Metastatic Soft Tissue Sarcoma
  • Besançon, France
  • +19 more
Dec 8, 2020

Myxoid Liposarcoma, Round Cell Liposarcoma, Stage III Soft Tissue Sarcoma AJCC v7 Trial in Seattle (procedure, other, drug)

Withdrawn
  • Myxoid Liposarcoma
  • +5 more
  • Biopsy
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Sep 6, 2019

Metastatic Soft Tissue Sarcoma Trial in Worldwide (MORAb-004, Gemcitabine, Docetaxel)

Completed
  • Metastatic Soft Tissue Sarcoma
  • Santa Monica, California
  • +28 more
Aug 1, 2019

Metastatic Soft Tissue Sarcoma, Locally Advanced Soft Tissue Sarcoma, Unresectable Soft Tissue Sarcoma Trial in Worldwide

Unknown status
  • Metastatic Soft Tissue Sarcoma
  • +2 more
  • Santa Monica, California
  • +33 more
Sep 12, 2013